Vardhini Desikan
Pediatric Endocrinology · Sleepy Hollow, NYNPI 1295984383
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 231 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations.
Across 231 payments — averaging $21.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$970
- Novo Nordisk$452
- Ascendis Pharma Endocrinology Inc$430
- Tolmar, Inc.$381
- Sanofi-aventis U.S. LLC$321
- Insulet Corporation$319
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,95599%
- Education$421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 51 | $970 |
| Novo Nordisk | 21 | $452 |
| Ascendis Pharma Endocrinology Inc | 15 | $430 |
| Tolmar, Inc. | 19 | $381 |
| Sanofi-aventis U.S. LLC | 10 | $321 |
| Insulet Corporation | 13 | $319 |
| Lilly USA, LLC | 10 | $234 |
| Azurity Pharmaceuticals, Inc. | 11 | $207 |
| Arbor Pharmaceuticals, Inc. | 11 | $170 |
| Medtronic(2 entities) | 7 | $161 |
| Biomarin Pharmaceutical Inc. | 2 | $138 |
| Endo Pharmaceuticals Inc. | 7 | $132 |
| Ultragenyx Pharmaceutical Inc. | 6 | $112 |
| Sandoz | 5 | $99 |
| Xeris Pharmaceuticals, Inc. | 5 | $96 |
| Endo USA, Inc. | 5 | $94 |
| Neurocrine Biosciences, Inc. | 3 | $89 |
| Amneal Pharmaceuticals LLC | 4 | $83 |
| Ipsen Biopharmaceuticals, Inc | 3 | $64 |
| Tandem Diabetes Care, Inc. | 4 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57 |
| Abbott | 2 | $47 |
| Eton Pharmaceuticals, Inc. | 1 | $43 |
| Tolmar Pharmaceuticals, Inc. | 2 | $42 |
| Pfizer | 3 | $41 |
| AstraZeneca | 1 | $31 |
| BETA Bionics, Inc. | 2 | $27 |
| IBSA Pharma Inc. | 2 | $24 |
| Rhythm Pharmaceuticals, Inc. | 1 | $21 |
| Mannkind Corporation | 1 | $19 |
| Intuity Medical Inc | 1 | $17 |
| Dexcom, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,997 in reported general payments places this provider in the 75th percentile of 138 pediatric endocrinology providers in New York.
Other pediatric endocrinology in Sleepy Hollow
- Alicia RomanoSleepy Hollow$157K
- Mary DamoreSleepy Hollow$4K
- Richard NotoSleepy Hollow$4K
- Paul SaengerMineola$180K
- Svetlana TenStaten Island$101K
- Robert RapaportNew York$98K
- Moris AnguloMineola$73K
- Jill BrodskyPoughkeepsie$45K
- Jorge Mejia-CorlettoNorth Babylon$44K
- Angela VerardoBronx$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.